8-K: Blum Holdings Q2 2025: Revenue Up, Net Loss Widens

Blum Holdings Inc. reported increased Q2 2025 revenue driven by a new retail location, but net loss widened despite reduced operating expenses.

Summary

• Revenue increased to $3.5 million in Q2 2025 from $2.2 million in Q1 2025, primarily due to contributions from a newly added Bay Area retail location.
• Gross margin improved to 49% in Q2 2025, up from 42% in Q2 2024, but decreased slightly from 53% in Q1 2025 due to initial inventory build and promotional pricing for a new store.
• Operating expenses were $2.5 million in Q2 2025, a 69% reduction from $8.0 million in Q2 2024, remaining stable compared to Q1 2025.
• Net loss from continuing operations was $1.9 million in Q2 2025, an increase of $1.3 million quarter-over-quarter from $0.6 million in Q1 2025.
• Adjusted EBITDA loss was $0.6 million for Q2 2025, compared to $0.4 million in Q1 2025.
• For the six months ended June 30, 2025, Adjusted EBITDA loss improved by 85% to $1.0 million, versus $7.0 million in the first half of 2024.
• Total assets increased by $14.6 million compared to year-end 2024, driven by the acquisition of a new retail dispensary in Northern California.
• Total liabilities increased by $16.4 million from year-end 2024, reflecting the consolidation of the acquired stores' tax obligation.
• On July 1st, a binding term sheet was entered to acquire another cannabis retail dispensary in Northern California, expected to add approximately $4.1 million in annualized revenue.
• On August 11th, an additional $0.5 million was secured from an accredited investor, bringing total capital raised in calendar year 2025 to $2.1 million.

Sentiment

Score: 5

Explanation: Mixed results. While revenue grew and operating expenses were significantly reduced year-over-year, the net loss and Adjusted EBITDA loss worsened quarter-over-quarter. The company is in a 'turnaround' and 'disciplined growth phase' with strategic acquisitions and capital raises, but also faces increasing liabilities and ongoing losses. The potential for tax liability reduction is a significant upside but contingent on future federal law changes.

Positives

• Revenue increased by 59% quarter-over-quarter, from $2.2 million in Q1 2025 to $3.5 million in Q2 2025, driven by a new retail location.
• Gross margin improved significantly year-over-year to 49% in Q2 2025 from 42% in Q2 2024.
• Operating expenses were reduced by 69% year-over-year to $2.5 million in Q2 2025 from $8.0 million in Q2 2024, reflecting a leaner cost structure and reduced litigation expense.
• Adjusted EBITDA loss for the six months ended June 30, 2025, improved by 85% to $1.0 million, compared to $7.0 million in the first half of 2024.
• Acquisition of a new retail dispensary in Northern California is expected to generate approximately $12.0 million in annualized revenue.
• Successfully raised $2.1 million in capital in calendar year 2025, including $0.5 million secured on August 11th.
• Management believes a significant portion of tax liabilities could be reduced or eliminated with the IRS upon legalization, representing potential long-term upside.

Negatives

• Net loss from continuing operations increased to $1.9 million in Q2 2025 from $0.6 million in Q1 2025, driven by lower gross margins and flat operating expenses during new location integration.
• Gross margin decreased slightly quarter-over-quarter from 53% in Q1 2025 to 49% in Q2 2025, mainly due to initial inventory build and promotional pricing for a new store.
• Adjusted EBITDA loss increased quarter-over-quarter to $0.6 million in Q2 2025 from $0.4 million in Q1 2025.
• Total liabilities increased by $16.4 million from year-end 2024, reflecting the consolidation of acquired stores' tax obligations.
• Stockholders' Deficit increased from $(4,744) thousand at December 31, 2024, to $(6,559) thousand at June 30, 2025.

Risks

• The ability to reduce or eliminate tax liabilities is contingent on potential future changes to federal cannabis tax laws (IRC Section 280E reform or federal rescheduling), which are uncertain.
• Integration of new retail locations may lead to initial inventory build and promotional pricing, potentially impacting gross margins.
• Reliance on short-term loans, convertible notes, and strategic investor participation for strengthening cash position and reducing high-cost debt carries inherent financial risks.
• Forward-looking statements are subject to risks and uncertainties, and actual results may differ materially from projections.
• New factors may emerge that are unpredictable, impacting the business and potentially causing actual results to differ from expectations.
• Risks associated with the acquisition of new dispensaries will be more fully discussed in the Company's SEC reports.

Future Outlook

The Company expects revenue and gross margins to improve over the coming quarters as new locations stabilize and purchasing consolidates. It remains focused on disciplined capital deployment, margin expansion, and selective mergers and acquisitions in core California markets. Management believes that a significant portion of tax liabilities could be reduced or eliminated with the IRS upon legalization, representing potential long-term upside for shareholders.

Management Comments

• Over the past year, we've moved from selling non-core assets and reducing overhead to adding profitable retail locations in markets where we see long-term opportunity.
• We've done this in a way that matches our resources and capital commitments from our investor partners, sometimes buying outright, sometimes operating under agreements that give us full control without tying up large amounts of cash.
• We're also breathing new life into our flagship high-potency brand and expanding our presence under globally recognized retail banners.
• These efforts are designed to improve margins, keep customers coming back, and make our stores a stronger platform for our own brands, our sister companies, and close partners.
• On the financial side, we continue to focus on strengthening our cash position and reducing high-cost debt through a mix of short-term loans, convertible notes, and strategic investor participation.
• This marks a shift from short-term crisis management to planning for sustainable mediumand long-term growth.

Industry Context

Blum Holdings operates in the U.S. cannabis sector, specifically in California, a market that could significantly benefit from potential future changes to federal cannabis tax laws, such as IRC Section 280E reform or federal rescheduling. The company's strategy of acquiring new retail locations and expanding its brand presence, including high-potency products, aligns with broader industry trends of consolidation and brand building in regulated cannabis markets. Its focus on disciplined growth and strategic M&A suggests an effort to capitalize on market opportunities while managing capital efficiently.

Comparison to Industry Standards

• No specific comparable companies, projects, or results were mentioned in the filing for direct comparison to industry standards.

Legal Proceedings

• The Company reported a substantial decrease in litigation expense, indicating a reduction in ongoing legal matters.

Stakeholder Impact

• Shareholders: Potential long-term upside from tax liability reduction upon federal cannabis legalization; short-term concerns due to increased net loss and liabilities. Strategic acquisitions aim to create value.
• Customers: Expansion of retail locations and focus on high-potency brands aim to improve customer experience and retention.
• Employees: Completion of restructuring suggests past workforce adjustments, with a current focus on a leaner cost structure.

Next Steps

• New locations are expected to stabilize.
• Purchasing is expected to consolidate.
• Disciplined capital deployment.
• Margin expansion initiatives.
• Selective mergers and acquisitions in core California markets.
• Actively evaluating strategies to address tax obligations, including potential future settlement opportunities under IRC Section 280E reform or federal rescheduling.

Key Dates

Recommendation

The company demonstrates strategic progress with quarter-over-quarter revenue growth and significant year-over-year operating expense reductions, driven by new acquisitions. However, the widening net loss and increased Adjusted EBITDA loss quarter-over-quarter, coupled with a substantial increase in liabilities due to acquired tax obligations, indicate ongoing financial challenges. The long-term upside is heavily reliant on uncertain federal cannabis tax law changes. Given the mixed financial performance and contingent future benefits, a 'hold' recommendation is appropriate until there is clearer evidence of sustained profitability and successful integration of new assets.

Keywords

Cannabis, Retail, Dispensary, California, Financial Results, Q2 2025, Revenue, Net Loss, EBITDA, Acquisition, Capital Raise, Tax Obligation, IRC Section 280E, Federal Rescheduling, Blum Holdings